Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities:
Net income	$ 3,400	$ 4,246
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	965	1,081
Amortization of right of use lease assets	181	312
Accretion related to acquisition, net	22	22
Amortization of subordinated debt issuance costs	65	65
Gain on redemption and retirement of subordinated notes	(656)	0
Provision for credit losses	1,185	341
Loss on sale of securities, net	176	0
Net amortization of securities	106	296
Decrease in loans held for sale, net	0	470
Net loss on write-down/sale of repossessed assets	336	36
Income from bank owned life insurance	(573)	(535)
Stock compensation expense	163	205
Decrease (increase) in other assets	184	(108)
Decrease in accrued expenses and other liabilities	(1,725)	(1,695)
Net cash provided by operating activities	3,829	4,736
Investing activities:
Purchases of available-for-sale securities	(5,886)	0
(Cash used in purchases) proceeds from redemption of restricted securities, net	(6)	1,351
Proceeds from maturities of available-for-sale securities	3,100	970
Proceeds from sales of available-for-sale securities	1,394	0
Paydowns on available-for-sale securities	7,313	9,131
Net decrease in loans held for investment	2,486	23,747
Purchases of premises and equipment	(323)	(1,951)
Net cash provided by investing activities	8,078	33,248
Financing activities:
(Decrease) increase in noninterest-bearing deposits	(12,479)	28,304
Increase (decrease) in savings deposits	17,501	(30,917)
(Decrease) increase in time deposits	(51,235)	8,791
Decrease in federal funds purchased, repurchase agreements and other borrowings, net	(646)	(1,002)
Increase in Federal Home Loan Bank advances	50	44,336
Repayment of Federal Home Loan Bank advances	0	(74,200)
Repayment and retirement of subordinated debt	(3,094)	0
Proceeds from Employee Stock Purchase Plan issuance	59	59
Cash dividends paid on common stock	(1,429)	(1,416)
Net cash used in financing activities	(51,273)	(26,045)
Net (decrease) increase in cash and cash equivalents	(39,366)	11,939
Cash and cash equivalents at beginning of period	140,044	80,806
Cash and cash equivalents at end of period	100,678	92,745
Cash payments for:
Interest	11,024	11,724
Income tax	760	0
Supplemental schedule of noncash transactions
Unrealized gain on securities available-for-sale	2,497	293
Loans transferred to repossessed assets	718	1,256
Impact of adoption of new accounting pronouncements	$ 0	$ 108